LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Thermo Fisher Presents Cascadion SM Clinical Analyzer and LC-MS IVD Medical Devices at EUROMEDLAB 2022

By LabMedica International staff writers
Posted on 12 Apr 2022
Print article
Image: Cascadion SM Clinical Analyzer (Photo courtesy of Thermo Fisher Scientific)
Image: Cascadion SM Clinical Analyzer (Photo courtesy of Thermo Fisher Scientific)

Thermo Fisher Scientific (Waltham, MA, USA) presented its Cascadion SM clinical analyzer and range of LC-MS IVD medical devices at EUROMEDLAB 2022.

Liquid chromatography-tandem mass spectrometry (LC-MS/MS) is considered the gold standard among vitamin D testing methods, but the technique has traditionally relied on sophisticated technology requiring specialized knowledge. The Cascadion SM clinical analyzer, equipped with a built-in 25-hydroxy vitamin D assay, automatically analyzes vitamin D2 and D3 in blood samples directly from qualified primary blood collection tubes, without the need for extensive technical expertise. Incorporating sample processing, LC separation and MS detection capabilities in a single solution, the Cascadion system is fully automated and enables load-up and walkaway sample management, eliminating the need for multiple connected components. The system offers end-to-end automation that is easy to use by any qualified laboratory personnel with minimal training, thus streamlining and optimizing the analytical process. The clinical analyzer is designed to simplify and accelerate the implementation of LC-MS/MS into routine clinical workflows.

Also on display at EUROMEDLAB 2022 was the Thermo Fisher family of LC-MS instruments for in vitro diagnostics that provides clinical labs with consistent reliable results, faster. These comprehensive, reliable LC-MS platform solutions offer greater flexibility than immunoassays, facilitate cost savings and enable clinical laboratories to achieve their productivity goals, while ensuring confidence in results of laboratory developed tests (LDTs). Thermo Fisher demonstrated the Vanquish MD HPLC which is the ideal chromatographic separations system for laboratories where analyte resolution is critical, alongside the TSQ Quantis MD Series mass spectrometer that is used by clinical diagnostic laboratories to meet routine requirements for laboratory tests. In addition, Thermo Fisher showcased the TSQ Altis MD Series mass spectrometer that is used by clinical diagnostic laboratories to address challenging analyte requirements for LDTs.

Related Links:
Thermo Fisher Scientific

Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Fecal DNA Extraction Kit
QIAamp PowerFecal Pro DNA Kit
New
Anti-HHV-6 IgM Assay
anti-HHV-6 IgM ELISA (semiquant.)

Print article

Channels

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Sekisui Diagnostics UK Ltd.